Stocks Comparison
Bristol Myers Squibb vs Merck: revenue, profit, margins and growth compared
Bristol Myers Squibb brought in $48.2B of revenue in fiscal 2025, Merck $65B in fiscal 2025. Revenue changed by -0.2% at Bristol Myers Squibb and +1.3% at Merck on the year before, so Merck grew faster. Bristol Myers Squibb kept 14.6% of its revenue as net profit, Merck 28.1%. Free cash flow was $12.8B at Bristol Myers Squibb and $12.4B at Merck.
Side by side, latest fiscal year
| BMY | MRK | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $48.2B | $65B |
| Revenue growth | -0.2% | +1.3% |
| Net income | $7.1B | $18.3B |
| Net margin | 14.6% | 28.1% |
| Free cash flow | $12.8B | $12.4B |
| Free cash flow margin | 26.7% | 19.0% |
| Earnings per share (diluted) | $3.46 | $7.28 |
| Cash | $10.2B | $14.6B |
| Debt | $44.8B | $49.1B |
| Price to earnings | 18.2 | 20.4 |
| Market value | $128.4B | $367.1B |
| Dividend yield | 3.96% | 2.20% |
| Rank by revenue in sector | #16 of 523 · Health care | #12 of 523 · Health care |
Over the years
Questions about Bristol Myers Squibb and Merck
Which is bigger by revenue, Bristol Myers Squibb or Merck?
Merck is bigger by revenue: $65B in fiscal 2025, against $48.2B for Bristol Myers Squibb in fiscal 2025.
Which keeps more of its revenue as profit, Bristol Myers Squibb or Merck?
Bristol Myers Squibb had a net margin of 14.6% in fiscal 2025; Merck had 28.1% in fiscal 2025.
Which grew revenue faster, Bristol Myers Squibb or Merck?
In their latest fiscal years revenue changed by -0.2% at Bristol Myers Squibb and +1.3% at Merck.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.